Skip to content

BDR Pharmaceutical launches generic drug for treating prostate cancer in India

The drug has been launched under the brand APATIDE in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant prostate cancer.

Read More

Leave a Reply

Generated by Feedzy
en_USEnglish
%d bloggers like this: